LyGenesis aims to grow a second liver within patient's own body
Interesting Engineering - 03-Apr-2024Scientists injected liver cells into a patient's lymph node, aiming to create a "mini liver"
LyGenesis
Organ regeneration using a patient's lymph nodes as bioreactors to grow ectopic organs
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end stage liver disease. Other therapeutic targets for organ regeneration include the thymus, pancreas, and kidney.
Visit website: https://www.lygenesis.com/
Details last updated 06-Oct-2019
LyGenesis News
LyGenesis raises $19 million to grow organs inside lymph nodes
Juvenescence - 24-Oct-2023Company's innovative approach could revolutionise organ transplantation
LyGenesis published new research showing new options for ectopic liver regeneration
Longevity Technology - 25-Jan-2022Could lead to alternative to whole-organ liver transplantation
Merger between regeneration companies AgeX and LyGenesis not going ahead
Business Wire - 23-Jul-2021Both companies to continue with the diverse technologies and product development
FDA approved LyGenesis' phase 2a trials on liver failure patients
Longevity Technology - 30-Dec-2020Raised $11M funding which goes into trials and developing functional organs
Display all news
People at LyGenesis
Eric Lagasse
Scientific Founder of LyGenesis and Associate Professor at the University of Pittsburgh.
Topics mentioned on this page:
Regenerative Medicine
